Clinical & Translational Oncology. 2007 Oct;9(10):652-62. [Link]
MuÃ±oz-Casares FC, RufiÃ¡n S, Rubio MJ, LizÃ¡rraga E, DÃaz-Iglesias C, Aranda E, Ciria R, MuntanÃ© J, Barrios P, Torres-Melero J, GonzÃ¡lez-Moreno S, GonzÃ¡lez-BayÃ³n L, Camps B, Bretcha P, FarrÃ© J, Ortega-PÃ©rez G, GÃ³mez-Portilla A.
Hospital Universitario Reina SofÃa. CÃ³rdoba, Spain.
Peritoneal carcinomatosis, considered years ago as a final stage of unresectable cancer, can now be managed with curative intention by means of a radical cytoreductive surgical procedure with associated peritonectomy and intraperitoneal chemotherapy, as described by Sugarbaker. Malignant neoplasms such as mesothelioma and pseudomyxoma peritonei, ovarian and colon cancer nowadays are experiencing some new therapeutical approaches. Higher survival rates can be reached in ovarian cancer, which is commonly diagnosed in the presence of peritoneal carcinomatosis, using an optimal cytoreductive radical surgery with intraperitoneal chemotherapy. An actualised review of the treatment of advanced ovarian cancer and a proposal of a national multicentre protocol for the treatment of peritoneal carcinomatosis from ovarian cancer has been performed by a group of Spanish surgeons and oncologists dedicated to a therapeutical approach to this pathology.